The use of hydroxyurea pretreatment in chronic myeloid leukemia in the current tyrosine kinase inhibitor era

Camille C.B. Kockerols*, Inge Geelen, Mark David Levin, Jeroen J.W.M. Janssen, Avinash G. Dinmohamed, Mels Hoogendoorn, Jan J. Cornelissen, Peter E. Westerweel

*Corresponding author for this work

Research output: Contribution to journalComment/Letter to the editorAcademicpeer-review

7 Citations (Scopus)
15 Downloads (Pure)
Original languageEnglish
Pages (from-to)1940-1943
Number of pages4
JournalHaematologica
Volume107
Issue number8
DOIs
Publication statusPublished - Aug 2022

Bibliographical note

Funding Information:
The Pharos-CML database was financially supported by grants from Novartis and BMS to the Netherlands Comprehensive Cancer Organisation (IKNL). The authors have no other conflicts of interest to disclose.

Cite this